​

Funding Round

Venture Round - Empress Therapeutics

Venture Round - Empress Therapeutics

Investment Firm

Overview

Empress Therapeutics is to generate transformative drug candidates that get to the clinic faster and cheaper.

Announced Date

Jun 21, 2023

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

Flagship Pioneering

Flagship Pioneering

Flagship Pioneering is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

1

Investor Name
Participant InvestorFlagship Pioneering

Round Details and Background

Empress Therapeutics raised $50000000 on 2023-06-21 in Venture Round

Empress Therapeutics is to generate transformative drug candidates that get to the clinic faster and cheaper.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 21, 2023
Venture Round - Empress Therapeutics
1-50.0M

Recent Activity

There is no recent news or activity for this profile.